• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

危重病患者早期多器官功能障碍生物标志物的风险预测。

Risk prediction of biomarkers for early multiple organ dysfunction in critically ill patients.

机构信息

Department of Emergency Medicine, University of Occupational and Environmental Health, 1-1 Iseigaoka, Yahata-nishi, Kitakyushu, 807-8555, Japan.

Department of Emergency and Critical Care Medicine, Chiba University Graduate School of Medicine, Chiba, Japan.

出版信息

BMC Emerg Med. 2021 Nov 8;21(1):132. doi: 10.1186/s12873-021-00534-z.

DOI:10.1186/s12873-021-00534-z
PMID:34749673
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8573766/
Abstract

BACKGROUND

Shock and organ damage occur in critically ill patients in the emergency department because of biological responses to invasion, and cytokines play an important role in their development. It is important to predict early multiple organ dysfunction (MOD) because it is useful in predicting patient outcomes and selecting treatment strategies. This study examined the accuracy of biomarkers, including interleukin (IL)-6, in predicting early MOD in critically ill patients compared with that of quick sequential organ failure assessment (qSOFA).

METHODS

This was a multicenter observational sub-study. Five universities from 2016 to 2018. Data of adult patients with systemic inflammatory response syndrome who presented to the emergency department or were admitted to the intensive care unit were prospectively evaluated. qSOFA score and each biomarker (IL-6, IL-8, IL-10, tumor necrosis factor-α, C-reactive protein, and procalcitonin [PCT]) level were assessed on Days 0, 1, and 2. The primary outcome was set as MOD on Day 2, and the area under the curve (AUC) was analyzed to evaluate qSOFA scores and biomarker levels.

RESULTS

Of 199 patients, 38 were excluded and 161 were included. Patients with MOD on Day 2 had significantly higher qSOFA, SOFA, and Acute Physiology and Chronic Health Evaluation II scores and a trend toward worse prognosis, including mortality. The AUC for qSOFA score (Day 0) that predicted MOD (Day 2) was 0.728 (95% confidence interval [CI]: 0.651-0.794). IL-6 (Day 1) showed the highest AUC among all biomarkers (0.790 [95% CI: 0.711-852]). The combination of qSOFA (Day 0) and IL-6 (Day 1) showed improved prediction accuracy (0.842 [95% CI: 0.771-0.893]). The combination model using qSOFA (Day 1) and IL-6 (Day 1) also showed a higher AUC (0.868 [95% CI: 0.799-0.915]). The combination model of IL-8 and PCT also showed a significant improvement in AUC.

CONCLUSIONS

The addition of IL-6, IL-8 and PCT to qSOFA scores improved the accuracy of early MOD prediction.

摘要

背景

由于对入侵的生物反应,重症患者在急诊科会出现休克和器官损伤,细胞因子在其发展过程中发挥重要作用。早期预测多器官功能障碍(MOD)很重要,因为这有助于预测患者的预后并选择治疗策略。本研究比较了细胞因子白细胞介素(IL)-6 等生物标志物与快速序贯器官衰竭评估(qSOFA)预测重症患者早期 MOD 的准确性。

方法

这是一项多中心观察性子研究。2016 年至 2018 年,来自五所大学。前瞻性评估了有全身炎症反应综合征表现的成年患者的数据,这些患者就诊于急诊科或入住重症监护病房。在第 0、1 和 2 天评估 qSOFA 评分和每个生物标志物(IL-6、IL-8、IL-10、肿瘤坏死因子-α、C 反应蛋白和降钙素原 [PCT])水平。主要结局是第 2 天的 MOD,分析曲线下面积(AUC)以评估 qSOFA 评分和生物标志物水平。

结果

在 199 名患者中,有 38 名被排除,161 名被纳入。第 2 天发生 MOD 的患者的 qSOFA、SOFA 和急性生理学和慢性健康评估 II 评分显著更高,且预后更差,包括死亡率。qSOFA 评分(第 0 天)预测第 2 天 MOD 的 AUC 为 0.728(95%置信区间[CI]:0.651-0.794)。所有生物标志物中,IL-6(第 1 天)的 AUC 最高(0.790 [95%CI:0.711-852])。qSOFA(第 0 天)和 IL-6(第 1 天)的组合显示出改善的预测准确性(0.842 [95%CI:0.771-0.893])。使用 qSOFA(第 1 天)和 IL-6(第 1 天)的组合模型也显示出更高的 AUC(0.868 [95%CI:0.799-0.915])。IL-8 和 PCT 的组合模型也显示 AUC 显著提高。

结论

将 IL-6、IL-8 和 PCT 添加到 qSOFA 评分中可提高早期 MOD 预测的准确性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e717/8576994/80f50debfda4/12873_2021_534_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e717/8576994/3ece05c85982/12873_2021_534_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e717/8576994/80f50debfda4/12873_2021_534_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e717/8576994/3ece05c85982/12873_2021_534_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e717/8576994/80f50debfda4/12873_2021_534_Fig2_HTML.jpg

相似文献

1
Risk prediction of biomarkers for early multiple organ dysfunction in critically ill patients.危重病患者早期多器官功能障碍生物标志物的风险预测。
BMC Emerg Med. 2021 Nov 8;21(1):132. doi: 10.1186/s12873-021-00534-z.
2
[Comparison of four early warning scores in predicting the prognosis of critically ill patients in secondary hospitals].[四种早期预警评分对二级医院重症患者预后预测的比较]
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2023 Oct;35(10):1093-1098. doi: 10.3760/cma.j.cn121430-20230614-00441.
3
Evaluation of qSOFA combined with inflammatory mediators for diagnosing sepsis and predicting mortality among emergency department.评价 qSOFA 联合炎症介质对急诊科脓毒症的诊断和死亡率预测的价值。
Clin Chim Acta. 2023 Apr 1;544:117352. doi: 10.1016/j.cca.2023.117352. Epub 2023 Apr 17.
4
Blood Interleukin-6 Levels Predict Multiple Organ Dysfunction in Critically Ill Patients.血液白细胞介素-6 水平可预测危重症患者多器官功能障碍。
Shock. 2021 Jun 1;55(6):790-795. doi: 10.1097/SHK.0000000000001678.
5
Combining quick Sequential Organ Failure Assessment with plasma lactate concentration is comparable to standard Sequential Organ Failure Assessment score in predicting mortality of patients with and without suspected infection.将快速序贯器官衰竭评估与血浆乳酸浓度相结合,在预测有或无疑似感染患者的死亡率方面,与标准序贯器官衰竭评估评分相当。
J Crit Care. 2017 Apr;38:1-5. doi: 10.1016/j.jcrc.2016.10.005. Epub 2016 Oct 18.
6
Comparison of qSOFA and SIRS for predicting adverse outcomes of patients with suspicion of sepsis outside the intensive care unit.qSOFA与SIRS用于预测非重症监护病房疑似脓毒症患者不良结局的比较。
Crit Care. 2017 Mar 26;21(1):73. doi: 10.1186/s13054-017-1658-5.
7
Sepsis patients in the emergency department: stratification using the Clinical Impression Score, Predisposition, Infection, Response and Organ dysfunction score or quick Sequential Organ Failure Assessment score?急诊科脓毒症患者:使用临床印象评分、易感性、感染、反应和器官功能障碍评分或快速序贯器官衰竭评估评分进行分层?
Eur J Emerg Med. 2018 Oct;25(5):328-334. doi: 10.1097/MEJ.0000000000000460.
8
Interleukin-6 Levels Act as a Diagnostic Marker for Infection and a Prognostic Marker in Patients with Organ Dysfunction in Intensive Care Units.白细胞介素-6水平作为重症监护病房感染的诊断标志物及器官功能障碍患者的预后标志物。
Shock. 2016 Sep;46(3):254-60. doi: 10.1097/SHK.0000000000000616.
9
[The prognostic value of serum procalcitonin on severity of illness in non-sepsis critically ill patients].[血清降钙素原对非脓毒症危重症患者病情严重程度的预后价值]
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2016 Aug;28(8):688-93. doi: 10.3760/cma.j.issn.2095-4352.2016.08.004.
10
The Role of Biomarkers and Scores in Describing Urosepsis.生物标志物和评分在描述尿脓毒症中的作用。
Medicina (Kaunas). 2023 Mar 17;59(3):597. doi: 10.3390/medicina59030597.

引用本文的文献

1
The impact of sedation and analgesia scores on prognosis in critically ill sepsis patients with sepsis-associated encephalopathy: a retrospective analysis.镇静和镇痛评分对伴有脓毒症相关性脑病的重症脓毒症患者预后的影响:一项回顾性分析
Front Neurol. 2025 Jun 25;16:1622964. doi: 10.3389/fneur.2025.1622964. eCollection 2025.
2
Biomarkers in Aneurysmatic and Spontaneous Subarachnoid Haemorrhage: A Clinical Prospective Multicentre Biomarker Panel Study of S100B, Claudin-5, Interleukin-10, TREM-1, TREM-2 and Neurofilament Light Chain As Well As Immunoglobulin G and M.动脉瘤性和自发性蛛网膜下腔出血中的生物标志物:一项关于S100B、Claudin-5、白细胞介素-10、触发受体表达分子-1(TREM-1)、触发受体表达分子-2(TREM-2)和神经丝轻链以及免疫球蛋白G和M的临床前瞻性多中心生物标志物组研究
Mol Neurobiol. 2025 Apr 28. doi: 10.1007/s12035-025-04889-3.
3

本文引用的文献

1
Blood Interleukin-6 Levels Predict Multiple Organ Dysfunction in Critically Ill Patients.血液白细胞介素-6 水平可预测危重症患者多器官功能障碍。
Shock. 2021 Jun 1;55(6):790-795. doi: 10.1097/SHK.0000000000001678.
2
Performance of the quick Sequential (sepsis-related) Organ Failure Assessment score as a prognostic tool in infected patients outside the intensive care unit: a systematic review and meta-analysis.快速序贯器官衰竭评估评分在重症监护室外感染患者中的预后工具性能:系统评价和荟萃分析。
Crit Care. 2018 Feb 6;22(1):28. doi: 10.1186/s13054-018-1952-x.
3
SIRS, qSOFA, and organ failure for assessing sepsis at the emergency department.
Association between serum endocan levels and organ failure in hospitalized patients with cirrhosis.肝硬化住院患者血清内脂素水平与器官衰竭之间的关联
PLoS One. 2024 Dec 26;19(12):e0315619. doi: 10.1371/journal.pone.0315619. eCollection 2024.
4
Continuous Biosensing to Monitor Acute Systemic Inflammation, a Diagnostic Need for Therapeutic Guidance.用于监测急性全身炎症的连续生物传感,这是治疗指导的诊断需求。
ACS Sens. 2025 Jan 24;10(1):4-14. doi: 10.1021/acssensors.4c02569. Epub 2024 Dec 18.
5
The relation between inflammatory biomarkers and drug pharmacokinetics in the critically ill patients: a scoping review.危重症患者炎症生物标志物与药物药代动力学的关系:范围综述。
Crit Care. 2024 Nov 19;28(1):376. doi: 10.1186/s13054-024-05150-4.
6
Development of a biomarker prediction model for post-trauma multiple organ failure/dysfunction syndrome based on the blood transcriptome.基于血液转录组的创伤后多器官衰竭/功能障碍综合征生物标志物预测模型的开发
Ann Intensive Care. 2024 Aug 28;14(1):134. doi: 10.1186/s13613-024-01364-5.
7
Therapeutic plasma exchange is feasible and tolerable in severely injured patients with trauma-induced coagulopathy.治疗性血浆置换对于创伤性凝血病的重伤患者是可行且可耐受的。
Trauma Surg Acute Care Open. 2024 Jan 5;9(Suppl 1):e001126. doi: 10.1136/tsaco-2023-001126. eCollection 2024.
8
Septic encephalopathy in the elderly - biomarkers of potential clinical utility.老年人脓毒症性脑病——具有潜在临床应用价值的生物标志物
Front Cell Neurosci. 2023 Sep 7;17:1238149. doi: 10.3389/fncel.2023.1238149. eCollection 2023.
9
Neonatal NET-Inhibitory Factor improves survival in the cecal ligation and puncture model of polymicrobial sepsis by inhibiting neutrophil extracellular traps.新生儿 NET 抑制因子通过抑制中性粒细胞胞外陷阱改善多微生物脓毒症盲肠结扎和穿刺模型中的存活率。
Front Immunol. 2023 Jan 17;13:1046574. doi: 10.3389/fimmu.2022.1046574. eCollection 2022.
10
Continuous renal replacement therapy combined with double filtration plasmapheresis in the treatment of severe lupus complicated by serious bacterial infections in children: A case report.连续性肾脏替代疗法联合双重滤过血浆置换治疗儿童重症狼疮合并严重细菌感染:1例病例报告
Open Life Sci. 2022 Sep 19;17(1):1256-1262. doi: 10.1515/biol-2022-0477. eCollection 2022.
用于急诊科评估脓毒症的全身炎症反应综合征、快速序贯器官功能衰竭评分及器官功能衰竭
J Thorac Dis. 2017 Jun;9(6):1459-1462. doi: 10.21037/jtd.2017.05.36.
4
Comparison of QSOFA score and SIRS criteria as screening mechanisms for emergency department sepsis.QSOFA评分与全身炎症反应综合征(SIRS)标准作为急诊科脓毒症筛查机制的比较。
Am J Emerg Med. 2017 Nov;35(11):1730-1733. doi: 10.1016/j.ajem.2017.07.001. Epub 2017 Jul 6.
5
Comparison of qSOFA and SIRS for predicting adverse outcomes of patients with suspicion of sepsis outside the intensive care unit.qSOFA与SIRS用于预测非重症监护病房疑似脓毒症患者不良结局的比较。
Crit Care. 2017 Mar 26;21(1):73. doi: 10.1186/s13054-017-1658-5.
6
qSOFA Has Poor Sensitivity for Prehospital Identification of Severe Sepsis and Septic Shock.qSOFA对院前严重脓毒症和脓毒性休克的识别敏感性较差。
Prehosp Emerg Care. 2017 Jul-Aug;21(4):489-497. doi: 10.1080/10903127.2016.1274348. Epub 2017 Jan 25.
7
Prognostic Accuracy of Sepsis-3 Criteria for In-Hospital Mortality Among Patients With Suspected Infection Presenting to the Emergency Department.Sepsis-3 标准对急诊科疑似感染患者住院死亡率的预后准确性。
JAMA. 2017 Jan 17;317(3):301-308. doi: 10.1001/jama.2016.20329.
8
Getting a consensus: advantages and disadvantages of Sepsis 3 in the context of middle-income settings.达成共识:中等收入环境下脓毒症3.0的利弊
Rev Bras Ter Intensiva. 2016 Oct-Dec;28(4):361-365. doi: 10.5935/0103-507X.20160068.
9
Systemic Inflammatory Response Syndrome, Quick Sequential Organ Function Assessment, and Organ Dysfunction: Insights From a Prospective Database of ED Patients With Infection.全身炎症反应综合征、快速序贯器官功能评估与器官功能障碍:来自急诊感染患者前瞻性数据库的见解
Chest. 2017 Mar;151(3):586-596. doi: 10.1016/j.chest.2016.10.057. Epub 2016 Nov 19.
10
Interleukin 6, galectin 3, growth differentiation factor 15, and soluble ST2 for mortality prediction in critically ill patients.白细胞介素6、半乳糖凝集素3、生长分化因子15和可溶性ST2对危重症患者死亡率的预测作用
J Crit Care. 2016 Aug;34:38-45. doi: 10.1016/j.jcrc.2016.03.020. Epub 2016 Mar 30.